Interleukin-6 N-Terminal Peptides Modulate the Expression of junB Protooncogene and the Production of Fibrinogen in HepG2 Cells

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biological chemistry

• Publication date

  2003-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/BC.2003.047PMID 12715892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, solution conformation and interleukin-6-related activities of interleukin-6 peptides.

  2009influential reference
• Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator.

  2009cited by this paper
• The action of interleukin 6 and leukaemia inhibitory factor on liver cells.

  2007cited by this paper
• C-Terminal Peptides of Interleukin-6 Modulate the Expression of junB Protooncogene and the Production of Fibrinogen by HepG2 Cells

  2001cited by this paper
• Transcriptional Control Mechanism of Fibrinogen Gene Expression

  2001cited by this paper
• Synthesis and characterization of 4-ethoxymethylene-2-[1]-naphthyl-5(4H)-oxazolone and its fluorescent amino acid derivatives

  2001cited by this paper
• Interleukin-6 signal transduction and lymphocyte function.

  2000cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• IL-6 Type Cytokine Receptor Complexes: Hexamer, Tetramer or Both?

  1999cited by this paper
• The STAT3-independent Signaling Pathway by Glycoprotein 130 in Hepatic Cells*

  1999cited by this paper
• Interleukin-6 and Leukemia Inhibitory Factor Induction of JunB Is Regulated by Distinct Cell Type-specific Cis-acting Elements*

  1999influential reference
• Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3.

  1998cited by this paper
• Interleukin-6 and related cytokines: effect on the acute phase reaction.

  1998cited by this paper
• Development of competitive mRNA PCR for the quantification of interleukin-6-responsive junB oncogene expression.

  1998cited by this paper
• Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

  1998cited by this paper
• Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.

  1998cited by this paper
• Interleukin 6 and its receptor: ten years later.

  1998cited by this paper
• Tertiary structural models of human interleukin-6 and evaluation by comparison with X-ray and NMR structures.

  1998cited by this paper
• Interleukin‐6: Structure‐function relationships

  1997cited by this paper
• Tertiary structural models for human interleukin‐6 and evaluation by a sequence‐structure compatibility method and NMR experimental information

  1997cited by this paper
• Solution structure of recombinant human interleukin-6.

  1997cited by this paper
• Hematopoietic effects of recombinant human interleukin-3 and interleukin-6

  1997cited by this paper
• 1.9 Å crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling

  1997influential reference
• Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor.

  1996cited by this paper
• Regulation by Spermine of Native Inward Rectifier K Channels in RBL-1 Cells (*)

  1996cited by this paper
• Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.

  1996influential reference
• Potential use of recombinant human interleukin-6 in clinical oncology.

  1996cited by this paper
• Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.

  1996influential reference
• Identification of residues in the putative 5th helical region of human interleukin‐6, important for activation of the IL‐6 signal transducer, gp130

  1996cited by this paper
• In Vitro Assembly of the Component Chains of Fibrinogen Requires Endoplasmic Reticulum Factors*

  1996cited by this paper
• Two distinct and independent sites on IL‐6 trigger gp 130 dimer formation and signalling.

  1995influential reference
• Cytokine signal transduction.

  1995cited by this paper
• The effect of WSEWS pentapeptide and WSEWS-specific monoclonal antibodies on constitutive and IL-6 induced acute-phase protein production by a human hepatoma cell line, HEPG-2.

  1995cited by this paper
• Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction.

  1995influential reference
• Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments.

  1995influential reference
• Jaks and Stats in signaling by the cytokine receptor superfamily.

  1995cited by this paper
• Development of Human IL‐6 Receptor Antagonists

  1995cited by this paper
• Soluble interleukin‐6 (IL‐6) receptor augments central effects of IL‐6 in vivo

  1995cited by this paper
• Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond.

  1995cited by this paper
• Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate--the marmoset.

  1994cited by this paper
• Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily

  1994cited by this paper
• Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.

  1994cited by this paper
• Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells

  1994cited by this paper
• Generation of interleukin‐6 receptor antagonists by molecular‐modeling guided mutagenesis of residues important for gp130 activation.

  1994influential reference
• Roles of disulfide bonds in recombinant human interleukin 6 conformation.

  1994cited by this paper
• Development of a human interleukin-6 receptor antagonist.

  1994influential reference
• Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate-- the marmoset

  1994cited by this paper
• Signal transduction. Just another signalling pathway.

  1994cited by this paper
• Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction.

  1994cited by this paper
• Cytokine signal transduction.

  1994cited by this paper
• Rapid generation of internal standards for competitive PCR by low-stringency primer annealing.

  1994cited by this paper
• Role of the C‐terminus in the activity, conformation, and stability of interleukin‐6

  1993cited by this paper
• Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression [published erratum appears in J Cell Biol 1993 Apr;121(2):following 477]

  1993cited by this paper
• Interleukin-6 in biology and medicine.

  1993influential reference
• Structure-function analysis of the C-terminal segment of human interleukin-6.

  1993cited by this paper
• Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level

  1993cited by this paper
• Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure.

  1993cited by this paper
• An altered repertoire of fos/jun (AP-1) at the onset of replicative senescence.

  1992cited by this paper
• Analysis of human/mouse interleukin‐6 hybrid proteins: both amino and carboxy termini of human interleukin‐6 are required for in vitro receptor binding

  1992cited by this paper
• Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance.

  1992cited by this paper
• Glycosylation of interleukin-6 purified from normal human blood mononuclear cells.

  1992cited by this paper
• Antitumor effects of human recombinant interleukin-6 on acute myeloid leukemia in mice and in cell cultures.

  1992cited by this paper
• Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.

  1992cited by this paper
• Internal deletions of amino acids 29‐42 of human interleukin‐6 (IL‐6) differentially affect bioactivity and folding

  1991influential reference
• Site‐specific mutagenesis of human interleukin‐6 and its biological activity

  1991cited by this paper
• Effects of site-specific mutations on biologic activities of recombinant human IL-6.

  1991cited by this paper
• Internal deletions in human interleukin-6: structure-function analysis.

  1991cited by this paper
• Structure‐function analysis of human interleukin‐6

  1990cited by this paper
• Preparation and Application of the 5-(4-(9-Fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)valeric Acid (PAL) Handle for the Solid-Phase Synthesis of C-Terminal Peptide Amides Under Mild Conditions.

  1990influential reference
• Haemopoietic receptors and helical cytokines.

  1990influential reference
• Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.

  1990influential reference
• Proton nuclear magnetic resonance study of human interleukin 6: chemical modifications and partial spectral assignments for the aromatic residues.

  1990influential reference
• Interleukin-6 and the acute phase response.

  1990cited by this paper
• jun: oncogene and transcription factor.

  1990cited by this paper
• Preparation and application of the 5-(4-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)-valeric acid (PAL) handle for the solid-phase synthesis of C-terminal peptide amides under mild conditions

  1990cited by this paper
• Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28.

  1989influential reference
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989influential reference
• An alternative regulatory pathway of the acute phase response: the role of fibroblast-derived interferon-β 2

  1988cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Stabilization of the ribonuclease S-peptide alpha-helix by trifluoroethanol.

  1986cited by this paper
• Stabilization of the ribonuclease S‐peptide α‐helix by trifluoroethanol

  1986cited by this paper
• COVALENT STRUCTURE OF FIBRINOGEN

  1983cited by this paper
• Direct determination of absolute circular dichroism data and calibration of commercial instruments

  1981cited by this paper
• Quantitation of cytoplasmic fibrinogen in rat liver cells.

  1977cited by this paper
• Circular dichroism of biological membranes. I. Mitochondria and red blood cell ghosts.

  1971cited by this paper
• Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

  1970cited by this paper
• Conformational Aspects of Synthetic Polypeptides. VI. Hypochromic Spectral Studies of Oligo-γ-Methyl-L-Glutamate Peptides

  1962cited by this paper

• Dual-specificity phosphatases in the hypo-osmotic stress response of keratin-defective epithelial cell lines.

  2008cites this paper